3 April 2017
Amicus Therapeutics has completed enrollment in the ongoing Phase 3 clinical study (ESSENCE) of the novel topical medicine SD-101 for people with EB.
24 January 2017
DEBRA International is now inviting expressions-of-interest for funding support targeting wound healing in EB.
29 November 2016
The ESSENCE Study is being made available to English-speaking EB patients at a site in Freiberg, Germany.
31 October 2016
Researchers at University College London are seeking participants for a study that looks at the impact of EB at mealtimes.